These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31888500)

  • 1. "Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study".
    Mardian Y; Yano Y; Ratnasari N; Choridah L; Wasityastuti W; Setyawan NH; Hayashi Y
    BMC Gastroenterol; 2019 Dec; 19(1):229. PubMed ID: 31888500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
    Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE.
    Lim J; Kim KW; Ko Y; Jang IY; Lee YS; Chung YH; Lee HC; Lim YS; Kim KM; Shim JH; Choi J; Lee D
    BMC Cancer; 2021 Oct; 21(1):1164. PubMed ID: 34715813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.
    Tachi Y; Kozuka A; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    Nutrition; 2018 Oct; 54():83-88. PubMed ID: 29753174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 9.  Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
    Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
    Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
    Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma.
    Yang JF; Huang WY; Lo CH; Lee MS; Lin CS; Shen PC; Dai YH; Wang YF; Chen TW
    Sci Rep; 2022 Nov; 12(1):19100. PubMed ID: 36352042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
    Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
    Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
    Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
    Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
    BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of body composition in hepatocellular carcinoma patients with immunotherapy.
    Zhang L; Li X; Wang K; Wu M; Liu W; Wang W
    Ann Med; 2024 Dec; 56(1):2395062. PubMed ID: 39189472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma.
    Levolger S; van Vledder MG; Muslem R; Koek M; Niessen WJ; de Man RA; de Bruin RW; Ijzermans JN
    J Surg Oncol; 2015 Aug; 112(2):208-13. PubMed ID: 26266324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
    Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
    Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
    Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
    Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
    J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.